Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from glandular epithelial cells of the gall bladder.
Biomarker and diagnostic research for gallbladder adenocarcinoma has been reported in the published literature.
4 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE3, 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
73 publications have been identified in PubMed for gallbladder adenocarcinoma. Research spans Case Report / Case Series (41%), Epidemiology / Natural History (22%), and Basic Science / Preclinical (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 30 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
41%
Disease patterns and progression | 16 | 22% |
Laboratory research | 9 | 12% |
Clinical study results | 8 | 11% |
Testing and diagnosis research | 6 | 8% |
Research summaries | 4 | 5% |
Kogami T (2026). [PMID: 41525292](https://pubmed.ncbi.nlm.nih.gov/41525292/). *Pathology international*. [Epidemiology / Natural History]
Matsushita M (2026). [PMID: 41511925](https://pubmed.ncbi.nlm.nih.gov/41511925/). *Pathobiology : journal of immunopathology, molecular and cellular biology*. [Basic Science / Preclinical]
Wang GY (2026). [PMID: 41028645](https://pubmed.ncbi.nlm.nih.gov/41028645/). *Annals of surgical oncology*. [Clinical Trial Publication]
Pérez Serena A (2026). [PMID: 41485750](https://pubmed.ncbi.nlm.nih.gov/41485750/). *Gastroenterologia y hepatologia*. [Case Report / Case Series]
Wu XJ (2026). [PMID: 42060015](https://pubmed.ncbi.nlm.nih.gov/42060015/). *J Gastrointest Cancer*. [Case Report / Case Series]
Ghosh R (2026). [PMID: 42023185](https://pubmed.ncbi.nlm.nih.gov/42023185/). *Indian J Surg Oncol*. [Basic Science / Preclinical]
Chen M (2026). [PMID: 42026847](https://pubmed.ncbi.nlm.nih.gov/42026847/). *Am J Case Rep*. [Case Report / Case Series]
Rompianesi G (2026). [PMID: 42084690](https://pubmed.ncbi.nlm.nih.gov/42084690/). *Ann Surg Oncol*. [Review / Meta-Analysis]
Gupta A (2026). [PMID: 41959966](https://pubmed.ncbi.nlm.nih.gov/41959966/). *Cureus*. [Case Report / Case Series]
Makdissi FF (2026). [PMID: 41694496](https://pubmed.ncbi.nlm.nih.gov/41694496/). *World journal of gastroenterology*. [Epidemiology / Natural History]
AI-curated news mentioning gallbladder adenocarcinoma
Updated Aug 29, 2026
A case report highlights a pathogenic germline variant in the CDH1 gene linked to hereditary diffuse gastric cancer and poorly differentiated gallbladder adenocarcinoma. This suggests a potential carcinogenic relationship between the stomach and gallbladder.